Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthconnROCO:6665 -1.80%73 EBITDA Margin % is 7.70% as of Dec. 2025, which is 43% below its 10-year median of 13.51. GuruFocus rates ROCO:6665 with a GF Score™ of 73/100 and a GF Value™ of NT$21.53 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 18 Healthcare Plans companies, Healthconn ranks better than 61.11% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Healthconn's EBITDA for the
six
months ended in Dec. 2025 was NT$45 Mil. Healthconn's Revenue for the
six
months ended in Dec. 2025 was NT$583 Mil. Therefore, Healthconn's EBITDA margin for the quarter that ended in Dec. 2025 was 7.70%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Healthconn EBITDA Margin % Related Terms
Healthconn EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Healthconn's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6665 vs UNH, CVS, ELV: EBITDA Margin % Comparison
For the Healthcare Plans subindustry, Healthconn's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthconn EBITDA Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Healthconn's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Healthconn's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthconn (ROCO:6665) has a EBITDA Margin % of 7.70% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Healthconn and its competitors. This is 43% below median its historical median of 13.51. Over the past decade, Healthconn's EBITDA Margin % has ranged from 6.26 to 46.28. According to the industry distribution chart, Healthconn ranks #7 out of 18 companies in the Healthcare Plans industry, placing it in the top 38.9%.
Is Healthconn's EBITDA Margin % too high?
Healthconn's current EBITDA Margin % of 7.70% is 43% below median its 10-year median of 13.51. Over the past 10 years, this metric has ranged from a low of 6.26 to a high of 46.28. The Healthcare Plans industry median EBITDA Margin % is 4.46. Healthconn's value of 7.70% is 72.6% above this industry median. Based on the distribution chart, Healthconn ranks #7 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Healthconn has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthconn's EBITDA Margin % compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Healthconn ranks #7 out of 18 companies for EBITDA Margin %. This puts Healthconn in the upper half of its industry. The industry median EBITDA Margin % is 4.46. Healthconn's value of 7.70% is 72.6% above this benchmark. Historically, Healthconn's own EBITDA Margin % has ranged from 6.26 to 46.28 over the past decade. While the company's 10-year median is 13.51 vs. the industry median of 4.46, Healthconn has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Plans company?
The median EBITDA Margin % among Healthcare Plans companies is 4.46, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthconn's current EBITDA Margin % of 7.70% is 72.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Healthconn and its competitors. For the Healthcare Plans industry, the median EBITDA Margin % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthconn's current EBITDA Margin % is 7.70%, which is 43% below median its own 10-year median of 13.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthconn stock overvalued right now?
Based on GuruFocus' analysis, Healthconn (ROCO:6665) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$21.53, compared to a current price of NT$19.10 — trading 11.3% below its estimated fair value. The current EBITDA Margin % is 7.70%, which is 43% below median its 10-year median of 13.51 and 72.6% above the Healthcare Plans industry median of 4.46. Healthconn's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Healthconn (ROCO:6665), the current EBITDA Margin % is 7.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthconn (ROCO:6665) Overvalued in 2026?
Based on GuruFocus' analysis, Healthconn stock appears to be undervalued.
The current stock price of NT$19.10 is trading 11.3% below its estimated GF Value™ of NT$21.53.
GuruFocus considers Healthconn to be Modestly Undervalued.
Key valuation signals for ROCO:6665:
EBITDA Margin %: 7.70% (43% below median its 10-year median of 13.51)
GF Value™: NT$21.53 vs. price of NT$19.10 (11.3% below fair value)
Industry Position: 72.6% above the Healthcare Plans median (#7 of 18)
No single metric tells the full story. See the ROCO:6665 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthconn Corp is a Taiwan-based company engaged in the provisions of healthcare services. The company offers product and services such as personal services and corporate services, health monitoring, and others. In addition, it also provides weight management services.
73GF Score
Get the complete analysis for ROCO:6665
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6665 has been successfully added to your 
